RxDoctor Payments Data

Zoya Bossen

Family · Land O Lakes, FLNPI 1518210830

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 88 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 15.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $915 and has fallen 98.3% since, to $15 in 2023.

$1,297in general payments, 2019–2025

Across 88 payments — averaging $14.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$205
  • Amarin Pharma, Inc.$153
  • Kowa Pharmaceuticals America, Inc.$131
  • Sanofi-aventis U.S. LLC$121
  • Boehringer Ingelheim$119
  • Bayer$105
  • plus $463 from 13 others

What the payments were for

  • Food & beverage$1,297100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,297 in reported general payments places this provider in the 75th percentile of 14,618 family providers in Florida.

See all family providers in Florida →

Other family in Land O Lakes

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →